FDA nominee: CBD shows promise, but many ‘open and unanswered questions’

FDA nominee: CBD shows promise, but many ‘open and unanswered questions’

The nominee to take charge of the U.S. Food and Drug Administration (FDA) says he wants to see more research to answer “open and unanswered questions” about CBD. Dr. Stephen Hahn, a cancer specialist from Houston who is awaiting Senate confirmation to lead the FDA, is telling U.S. senators that CBD already has “a pathway […]

FDA nominee: CBD shows promise, but many ‘open and unanswered questions’ is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

* This article was originally published here

Please follow and like us: